AD |
Alzheimer’s disease |
AP-1 |
Activator protein 1 |
CaMKII |
Calcium/calmodulin-dependent protein kinase II |
cAMP |
Cyclic adenosine monophosphate |
CMA |
Chaperone-mediated autophagy |
CSF |
Cerebrospinal fluid |
DLB |
Dementia with Lewy bodies |
DRD |
Dopa-responsive dystonia (Segawa disease) |
ERK |
Extracellular signal-regulated kinase |
FABP |
Fatty acid-binding protein |
GTP |
guanosine triphosphate |
GCH1 |
GTP cyclohydrolase 1 |
Hsc70 |
Heat shock cognate protein of 70 kDa |
L-DOPA |
L-3,4-dihydroxyphenylalanine |
LAMP |
Lysosome-associated membrane protein |
LRRK2 |
Leucine-rich repeat kinase 2 |
MAPK |
mitogen-activated protein kinase |
MAPKAPK |
Mitogen-activated protein kinase activated protein kinase |
MPP+ |
1-methyl-4-phenylpyridinium |
MPTP |
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
MSK1 |
Mitogen- and stress-activated kinase 1 |
NGF |
Nerve growth factor |
Nurr1 |
Nuclear receptor related-1 |
PD |
Parkinson’s disease |
PP2A |
Protein phosphatase 2a |
pSer40-TH |
Tyrosine hydroxylase phosphorylated at Ser40 |
SNpc |
Substantia nigra pars compacta |
SRF |
Serum-responsive factor |
TH |
Tyrosine hydroxylase |
VTA |
Ventral tegmental area |